Internal and external validation of comprehensive high-frequency activity biomarkers for epilepsy surgery
Clinical Neurophysiology · 2026-10 · 190 · 2111981
DOI: 10.1016/j.clinph.2026.2111981 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical Neurophysiology, 2026-10. Verfasst von Keisuke Hatano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Electrocorticography, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, The Uehara Memorial Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
OBJECTIVE: To validate models incorporating intracranial EEG-derived high-frequency activity (HFA) biomarkers for predicting the seizure onset zone (SOZ) and postsurgical seizure outcomes across independent cohorts and etiologies. METHODS: We quantified interictal HFA occurrence rates together with a comprehensive set of morphological features in people with drug-resistant epilepsy in a derivation cohort (N = 142), a temporal external cohort (N = 35), and two geographical external cohorts (N = 26 and N = 30). We developed models for SOZ localization using data from the 79 derivation cohort individuals who achieved postoperative seizure freedom. Model performance for SOZ localization and postoperative seizure outcome prediction was subsequently evaluated in the derivation, temporal external, and geographical external cohorts. RESULTS: HFA rate, spectral entropy, and power emerged as the most influential features for accurate SOZ classification. The model identified SOZ sites with areas under the curve (AUCs) up to 0.85, 0.86, and 0.75 in the derivation, temporal external, and geographical external cohorts, respectively. The model predicted postoperative seizure freedom in the derivation cohort (AUC up to 0.70) but failed to predict outcomes reliably in external cohorts. Among individuals in the external cohorts with MRI-nonlesional epilepsy, postoperative seizure freedom was predicted with an AUC of up to 0.73, whereas performance declined to 0.46 or lower among individuals with encephalomalacia. CONCLUSIONS: Integration of HFA rates with morphological features yields an SOZ-localization biomarker with cross-center generalizability, whereas postoperative outcome prediction remains dependent on underlying etiology. SIGNIFICANCE: A surgical strategy prioritizing resection of HFA-involved areas may be ineffective in individuals with encephalomalacia, underscoring the need for etiology-specific interpretation of HFA biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, MI 48201, USA.
- Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, MI 48201, USA; Department of Epileptology, Tohoku University Graduate School of Medicine, Sendai 980857…
- Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, MI 48201, USA; Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, O…
- Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, MI 48201, USA; Department of Neurosurgery, University of Tsukuba, Tsukuba, Ibaraki 3058575, Japan.
- Department of Neurosurgery, Children's Hospital of Michigan, Detroit Medical Center, Detroit, MI 48201, USA.
- Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, MI 48201, USA; Department of Neurology, Children's Hospital of Michigan, Detroit Medical Center, Wayne…
Förderung
- NINDS NIH HHS
- The Uehara Memorial Foundation
- Japan Society for the Promotion of Science
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Hatano, K., Kuroda, N., Uda, H., Sakakura, K., Cools, M. J., Luat, A. F., Osawa, S. I., Nemoto, H., Ukishiro, K., Endo, H., Nakasato, N., Takayama, Y., Iijima, K., Iwasaki, M., & Asano, E. (2026). Internal and external validation of comprehensive high-frequency activity biomarkers for epilepsy surgery. Clinical Neurophysiology, 190, 2111981. https://doi.org/10.1016/j.clinph.2026.2111981
Vancouver
Hatano K, Kuroda N, Uda H, Sakakura K, Cools MJ, Luat AF, et al. Internal and external validation of comprehensive high-frequency activity biomarkers for epilepsy surgery. Clinical Neurophysiology. 2026;190:2111981. doi:10.1016/j.clinph.2026.2111981
BibTeX
@article{Hatano2026,
author = {Hatano, Keisuke and Kuroda, Naoto and Uda, Hiroshi and Sakakura, Kazuki and Cools, Michael J and Luat, Aimee F and Osawa, Shin-Ichiro and Nemoto, Hitoshi and Ukishiro, Kazushi and Endo, Hidenori and Nakasato, Nobukazu and Takayama, Yutaro and Iijima, Keiya and Iwasaki, Masaki and Asano, Eishi},
title = {Internal and external validation of comprehensive high-frequency activity biomarkers for epilepsy surgery},
journal = {Clinical Neurophysiology},
year = {2026},
volume = {190},
pages = {2111981},
doi = {10.1016/j.clinph.2026.2111981}
}
EUVIMED